Photopheresis Abates the Anti-HLA Antibody Titer and Renal Failure Progression in Chronic Antibody-Mediated Rejection

Photopheresis Abates the Anti-HLA Antibody Titer and Renal Failure Progression in Chronic Antibody-Mediated Rejection

Objective: Chronic renal antibody-mediated rejection (ABMR) is a common cause of allograft failure, but an effective therapy is not available. Extracorporeal photopheresis (ECP) has been proven successful in chronic lung and heart rejection, and graft versus host disease. The aim of this study was t...

Full description

Bibliographic Details
Main Authors:	Marilena Gregorini, Claudia Del Fante, Eleonora Francesca Pattonieri, Maria Antonietta Avanzini, Maria Antonietta Grignano, Irene Cassaniti, Fausto Baldanti, Giuditta Comolli, Angela Nocco, Miriam Ramondetta, Gianluca Viarengo, Vincenzo Sepe, Carmelo Libetta, Catherine Klersy, Cesare Perotti, Teresa Rampino
Format:	Article
Language:	English
Published:	MDPI AG 2021-06-01
Series:	Biology
Subjects:	lymphocytes subset chronic allograft rejection kidney transplantation extracorporeal photopheresis proteinuria, Donor-Specific-Antibody
Online Access:	https://www.mdpi.com/2079-7737/10/6/547

Similar Items

Exosomal-miRNas expression and growth factors released by mononuclear cells of CLAD patients in response to extracorporeal photopheresis
by: Sara Bozzini, et al.
Published: (2024-03-01)

Lessons from the discontinuation of extracorporeal photopheresis
by: Kyle R. Brownback
Published: (2017-06-01)

PHOTOPHERESIS IN THE COMPREHENSIVE TREATMENT OF UROGENITAL REACTIVE ARTHRITIS (REITER’S DISEASE)
by: M. S. Petrova, et al.
Published: (2016-02-01)

Extracorporeal photopheresis: Review of technical aspects
by: Satyam Arora, et al.
Published: (2017-01-01)

Extracorporeal photopheresis in solid organ transplantation
by: A. V. Kildyushevsky, et al.
Published: (2020-10-01)

OF PHOTOPHERESIS IN KIDNEY TRANSPLANTATION
by: A. P. Faenko, et al.
Published: (2018-04-01)

A survey of extracorporeal photopheresis treatment in pediatric patients in the United Kingdom
by: Aisling M. Flinn, et al.
Published: (2020-07-01)

THE PATHOGENETIC SUBSTANTIATION OF EFFICIENCY OF PHOTOPHERESIS IN ATYPICAL VARIANTS OF LICHEN PLANUS
by: Yulia V. Molochkova, et al.
Published: (2018-04-01)

Extracorporeal Photopheresis in Dermatological Diseases
by: Hanna Terhaar, et al.
Published: (2024-03-01)

A European Multi-Center Analysis of Extracorporeal Photopheresis as Therapy for Chronic Lung Allograft Dysfunction
by: Alberto Benazzo, et al.
Published: (2024-01-01)

Extracorporeal Photopheresis in Children with Chronic Graft-Versus-Host Disease
by: Andrey Kozlov, et al.
Published: (2021-08-01)

Photopheresis efficacy in the treatment of rheumatoid arthritis: a pre-clinical proof of concept
by: Céline Coppard, et al.
Published: (2019-09-01)

Beyond 8-methoxypsoralen as the photosensitizer for extracorporeal photopheresis
by: Yandy Marx Castillo-Aleman
Published: (2022-10-01)

Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma
by: Nadia Ninosu, et al.
Published: (2023-12-01)

Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults
by: Cécile Robinson, et al.
Published: (2017-03-01)

Extracorporeal photopheresis in the treatment of the novel coronavirus disease COVID-19 (a case series)
by: A. V. Kildyushevsky, et al.
Published: (2020-09-01)

What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?
by: Oleg E. Akilov
Published: (2023-09-01)

Preliminary results on long-term follow-up of systemic sclerosis patients under extracorporeal photopheresis
by: Thilo Gambichler, et al.
Published: (2022-05-01)

Quilty Effect after Extracorporeal Photopheresis in a Patient with Severe Refractory Cardiac Allograft Rejection
by: Özgür Ulaş Özcan, et al.
Published: (2014-12-01)

Extracorporeal photopheresis reduces inflammation and joint damage in a rheumatoid arthritis murine model
by: Yuwei Lin, et al.
Published: (2024-03-01)

Immune Monitoring Assay for Extracorporeal Photopheresis Treatment Optimization After Heart Transplantation
by: Maja-Theresa Dieterlen, et al.
Published: (2021-08-01)

Fotoferese extracorpórea Extracorporeal photopheresis
by: Márcia M. Silva, et al.
Published: (2008-04-01)

Extracorporeal photopheresis in the treatment of graft-versus-host disease
by: I. V. Guz, et al.
Published: (2016-03-01)

Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis
by: Mauricio Sarmiento Maldonado, et al.
Published: (2017-12-01)

Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers
by: Ines Bojanic, et al.
Published: (2023-02-01)

Extracorporeal Photopheresis (ECP) and the Potential of Novel Biomarkers in Optimizing Management of Acute and Chronic Graft vs. Host Disease (GvHD)
by: Matthew Mankarious, et al.
Published: (2020-01-01)

A Critical Appraisal of Extracorporeal Photopheresis as a Treatment Modality for Acute and Chronic Graft-Versus-Host Disease
by: Hind Rafei, et al.
Published: (2017-10-01)

Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sézary syndrome
by: Ilana D. Breen, BS, et al.
Published: (2021-03-01)

Successful treatment of refractory checkpoint inhibitor‐induced hepatitis with quadruple therapy including extracorporeal photopheresis and infliximab
by: Inga Hansen, et al.
Published: (2024-03-01)

Effective Extracorporeal Photopheresis of Patients with Transplantation Induced Acute Intestinal GvHD and Bronchiolitis Obliterans Syndrome
by: Robin Reschke, et al.
Published: (2022-08-01)

Tregs and GvHD prevention by extracorporeal photopheresis: observations from a clinical trial
by: Crocchiolo Roberto, et al.
Published: (2021-02-01)

Extracorporeal photopheresis for the treatment of chronic graft versus host disease
by: Emin Kansu, et al.
Published: (2022-12-01)

Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010–2015
by: You-Li Ling, et al.
Published: (2020-01-01)

Extracorporeal photopheresis as a non-specific immune therapy of autoimmune diseases and skin T-cell lymphoma (a review of the literature and own studies)
by: A. V. Kil'dyushevskiy, et al.
Published: (2019-11-01)

Treatment of graft versus host disease with photopheresis interferes in voriconazole therapeutic drug monitoring: A case study
by: Adriana Sassone, et al.
Published: (2023-11-01)

Extracorporeal photopheresis in chronic graft-versus-host disease: clinical description and economic study
by: Dora Fraga Vargas, et al.
Published: (2023-04-01)

Persistent Neutropenia after ABOi Kidney Transplantation: A Case Report
by: Gabriele Gualtiero Andenna, et al.
Published: (2021-05-01)

Application experience of extracorporeal photopheresis for treatment of acute “graft-versus-host” disease after allogeneic hematopoietic stem cell transplantation
by: A. V. Kozlov, et al.
Published: (2014-07-01)

Application experience of extracorporeal photopheresis for treatment of acute “graft-versus-host” disease after allogeneic hematopoietic stem cell transplantation
by: A. V. Kozlov, et al.
Published: (2014-07-01)

Spectacular and Prompt Response to Extracorporeal Photopheresis for Refractory Cutaneous Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report
by: Adrianna Spałek, et al.
Published: (2022-11-01)